well such a huge pricing gap between bid/ask is clearly a sign of "information vacuum".but as an earlier intelligent post claimed - it's all "emotive crud".so tell that to the market.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
